Professor Emeritus of Pediatrics
[email protected]
Available to mentor
Raymond J Hutchinson
Professor Emeritus/a
-
Center MemberMM-PKUHSC Joint Institute
-
Pan W, Chaudhary N, Sedig L, Edmonds A, Hutchinson R, Demirci H. Am J Ophthalmol Case Rep, 2023 Dec; 32: 101941Journal ArticleScleral ectasia stabilization following intra-arterial chemotherapy in an eye with recurrent retinoblastoma.
DOI:10.1016/j.ajoc.2023.101941 PMID: 37915729 -
Chang E, Zhou Y, Musch D, Edmonds A, Sedig L, Hutchinson R, Chaudhary N, Demirci H. Graefes Arch Clin Exp Ophthalmol, 2023 Sep; 261 (9): 2679 - 2687.Journal ArticleComparing internal versus external carotid artery branch delivery of intraarterial chemotherapy for the treatment of retinoblastoma.
DOI:10.1007/s00417-023-06037-w PMID: 37010593 -
Kuisell C, Ploutz-Snyder R, Williams DA, Voepel-Lewis T, Hutchinson RJ, Dudding KM, Bridges C, Lavoie Smith EM. Clin J Pain, 2023 Jul 1; 39 (7): 326 - 333.Journal ArticleAdolescents and Young Adults With Sickle Cell Disease: Nociplastic Pain and Pain Catastrophizing as Predictors of Pain Interference and Opioid Consumption.
DOI:10.1097/AJP.0000000000001119 PMID: 37083638 -
Whitlock JA, Malvar J, Dalla-Pozza L, Goldberg JM, Silverman LB, Ziegler DS, Attarbaschi A, Brown PA, Gardner RA, Gaynon PS, Hutchinson R, Huynh VT, Jeha S, Marcus L, Messinger Y, Schultz KR, Cassar J, Locatelli F, Zwaan CM, Wood BL, Sposto R, Gore L. Pediatr Blood Cancer, 2022 Nov; 69 (11): e29901Journal ArticleNelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR).
DOI:10.1002/pbc.29901 PMID: 35989458 -
Tasian SK, Silverman LB, Whitlock JA, Sposto R, Loftus JP, Schafer ES, Schultz KR, Hutchinson RJ, Gaynon PS, Orgel E, Bateman CM, Cooper TM, Laetsch TW, Sulis ML, Chi Y-Y, Malvar J, Wayne AS, Rheingold SR. Haematologica, 2022 Oct 1; 107 (10): 2295 - 2303.Journal ArticleTemsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001).
DOI:10.3324/haematol.2021.279520 PMID: 35112552 -
Pommert L, Schafer ES, Malvar J, Gossai N, Florendo E, Pulakanti K, Heimbruch K, Stelloh C, Chi Y-Y, Sposto R, Rao S, Huynh VT, Brown P, Chang BH, Colace SI, Hermiston ML, Heym K, Hutchinson RJ, Kaplan JA, Mody R, O'Brien TA, Place AE, Shaw PH, Ziegler DS, Wayne A, Bhojwani D, Burke MJ. Am J Hematol, 2022 May; 97 (5): 613 - 622.Journal ArticleDecitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.
DOI:10.1002/ajh.26510 PMID: 35180323 -
Sedig LK, Spruit JL, Southwell J, Paul TK, Cousino MK, McCaffery H, Pituch K, Hutchinson R. Pediatr Blood Cancer, 2022 Mar; 69 (3): e29391Journal ArticlePalliative care is not associated with decreased intensity of care: Results of a chart review from a large children's hospital.
DOI:10.1002/pbc.29391 PMID: 34606158 -
Grondin C, Cong Y, Keshavarzi N, Geisser ME, Kolars JC, Hutchinson RJ. Account Res, 2022 Jul; 29 (5): 294 - 308.Journal ArticleEthical Perspectives of Chinese and United States Physicians at Initiation of a Research Collaborative.
DOI:10.1080/08989621.2021.1920014 PMID: 33877028